Finance

Lists
TRIB:NASDAQ
Trinity Biotech PLC
7,11 $
0,00%
(0,00) 1D
26 қаз., 15:53:39 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRIB...
Mkt. cap
5,78 млн
Avg. vol.
13,45 мың
Volume
347,00
52-wk high
52,50 $
52-wk low
5,05 $
EPS
-60,36 $
Beta
0,96
Shares outstanding
813,13 м.
No. of employees
287
Mkt. cap
5,78 млн
Avg. vol.
13,45 мың
Volume
347,00
52-wk high
52,50 $
52-wk low
5,05 $
EPS
-60,36 $
Beta
0,96
Shares outstanding
813,13 м.
No. of employees
287
News stories
From web sources and news partners
About Trinity Biotech PLC
CEO-
Employees287
Founded1992
Headquarters-
SectorMedical device
Websitetrinitybiotech.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
2026 ж. 30 сәу.
Fiscal period
Q4 2025
- / -5,10 $
Revenue / Est. (USD)
11,07 млн / 15,00 млн
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. нау.
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
Revenue
7,57 млн
10,83 млн
14,31 млн
11,07 млн
Cost of goods sold
5,66 млн
6,22 млн
7,84 млн
7,17 млн
Cost of revenue
5,66 млн
6,22 млн
7,84 млн
7,17 млн
Research and development expenses
1,12 млн
638,00 м.
817,00 м.
1,06 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,52 млн
6,98 млн
6,19 млн
5,78 млн
Operating expense
6,64 млн
7,62 млн
6,98 млн
5,00 млн
Total operating expenses
12,30 млн
13,83 млн
14,82 млн
12,18 млн
Operating income
-4,73 млн
-3,00 млн
-509,00 м.
-1,10 млн
Other non operating income
630,00 м.
1,18 млн
-1,52 млн
474,00 м.
EBT including unusual items
-8,79 млн
-5,67 млн
-5,06 млн
-17,65 млн
EBT excluding unusual items
-7,04 млн
-5,13 млн
-5,36 млн
-3,89 млн
Income tax expense
6,00 мың
294,00 м.
73,00 мың
-174,00 м.
Effective tax rate
-0,07%
-5,18%
-1,44%
0,99%
Other operating expenses
-
-
-30,00 мың
-1,84 млн
Net income
-8,80 млн
-5,97 млн
-5,14 млн
-17,48 млн
Net profit margin
-116,21%
-55,09%
-35,88%
-157,84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,94 млн
-3,31 млн
-3,33 млн
-3,26 млн
Net interest expenses
-2,94 млн
-3,31 млн
-3,33 млн
-3,26 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,09 млн
-2,35 млн
151,00 м.
-779,25 м.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары